Skip to main navigation Skip to search Skip to main content

Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116+ pericytes in cancer metastasis

Xiaoya Pei (Co-first Author), Zhichao Liu (Co-first Author), Lin Tang (Co-first Author), Junpeng Zhang (Co-first Author), Yan He, Xiaowan Zhuang, Yuxiang Song, Shaocong Peng, Yahui Zhao, Xuanzhang Huang, Yiwei Xu, Junyi Li, Liang Peng, Xingyuan Shi, Fan Zhang, Chong Liu, Mingliang He, Wei Dai, Liang Wu, Simon LawJinbao Liu, Zhenning Wang*, Zhigang Li*, Wenwen Xu*, Zhihua Liu*, Bin Li*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Tumor metastasis leads to most cancer deaths. However, how cellular diversity and dynamic cooperation within the tumor microenvironment contribute to metastasis remains poorly understood. Here we leverage single-cell multi-omics (16 samples, 117,169 cells) and spatial transcriptomics (five samples, 195,366 cells) to uncover the cellular and spatial architecture of esophageal squamous cell carcinoma (ESCC), and characterize an immunosuppressive GPR116+ pericyte subset promoting tumor metastasis and immunotherapy resistance. GPR116+ pericyte enrichment is transcriptionally regulated by PRRX1, evidenced by pericyte-specific Prrx1 knockout mice. Mechanistically, GPR116+ pericytes secrete EGFL6 to bind integrin β1 on cancer cells, activating the NF-κB pathway to facilitate metastasis. Serum EGFL6 serves as a noninvasive biomarker for the diagnosis and prognosis of several tumors. Blocking integrin β1 suppresses metastasis and improves immunotherapy response in animal models of ESCC. Collectively, we provide a spatially resolved landscape of the prometastatic tumor microenvironment in ESCC and highlight the biological and clinical importance of GPR116+ pericytes, proposing potential innovative therapeutic strategies for metastatic cancers. © The Author(s), under exclusive licence to Springer Nature America, Inc. 2025.
Original languageEnglish
Pages (from-to)2494-2508
JournalNature Genetics
Volume57
Issue number10
Online published10 Oct 2025
DOIs
Publication statusPublished - Oct 2025

Funding

This work was supported by the National Natural Science Foundation of China (no. 82273141 to B.L., no. 82273368 to W.W.X. and no. 82073196 to W.W.X.), the Outstanding Youth Program of Guangdong Natural Science Research (no. 2023B1515020012 to W.W.X.), the Guangdong Natural Science Research International joint project (no. 2023A0505050165 to B.L.), the Science and Technology Program of Guangzhou (no. 2023A03J0425 to B.L. and no. 2025A03J3288 to F.Z.), the Guangzhou Education Bureau Yangcheng Scholar Research Project (no. 202235385 to B.L.), the Key Laboratory of Guangdong Higher Education Institutes (no. 2021KSYS009 to B.L.) and the key disciplines of medicine of Guangzhou (no. 2025-2027 to B.L.).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116+ pericytes in cancer metastasis'. Together they form a unique fingerprint.

Cite this